Litcius/Paper detail

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

Alison Birtle, Mark Johnson, John Chester, Robert J. Jones, David Dolling, Richard T. Bryan, Christopher Harris, Andrew Winterbottom, Anthony Blacker, James W.F. Catto, Prabir Chakraborti, Jenny Donovan, Paul Anthony Elliott, Ann French, Satinder Jagdev, Benjamin Jenkins, Francis X. Keeley, Roger Kockelbergh, Thomas Powles, John Wagstaff, Caroline Wilson, Rachel Todd, Rebecca Lewis, Emma Hall

2020The Lancet527 citationsDOIOpen Access PDF

Topics & Concepts

MedicineOpen labelAdjuvantUrothelial carcinomaAdjuvant chemotherapyOncologyChemotherapyInternal medicineCarcinomaRandomized controlled trialUrologyCancerBladder cancerBreast cancerBladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesRenal cell carcinoma treatment
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial | Litcius